Cannabinoid CBG reduced anxiety and stress in first human clinical trial
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…
Amyris scaled first fermentation-based cannabinoid
On Sept. 1, 2020, Amyris announced that it had successfully scaled up the commercial production of Cannabigerol (CBG)…